ARCH Venture Fund VII, L.P.

CIK 000140243912 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001402439

Recent Transactions

50 trades

Conversion
908 Devices Inc.$MASS
Series C Preferred Stock
2020-12-22−669,977→ 0 total
Conversion
908 Devices Inc.$MASS
Series D Preferred Stock
2020-12-22−665,661→ 0 total
Conversion
908 Devices Inc.$MASS
Common Stock, par value $0.001
2020-12-22+5,425,045→ 5,425,045 total
Purchase
908 Devices Inc.$MASS
Common Stock, par value $0.001
2020-12-22$20.00/sh+300,000→ 5,725,045 total
Conversion
908 Devices Inc.$MASS
Series B Preferred Stock
2020-12-22−981,443→ 0 total
Conversion
908 Devices Inc.$MASS
Series E Preferred Stock
2020-12-22−180,578→ 0 total
Conversion
908 Devices Inc.$MASS
Series A Preferred Stock
2020-12-22−2,927,386→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-07-17$7.70/sh−34,521→ 4,242,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-07-16$7.81/sh−25,779→ 4,276,572 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-07-15$8.27/sh−2,700→ 4,302,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-14$8.15/sh−43,000→ 4,305,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-13$7.89/sh−81,591→ 4,350,871 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-13$8.20/sh−2,820→ 4,348,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-12$7.37/sh−40,092→ 4,432,462 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-11$6.49/sh−44,878→ 4,472,554 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-08$6.93/sh−84,496→ 4,517,432 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-07$6.87/sh−35,209→ 4,601,928 total
Conversion
Syros Pharmaceuticals, Inc.
Series A-1 Preferred Stock
2016-07-06−1,000,000→ 0 total
Conversion
Syros Pharmaceuticals, Inc.
Series A-2 Preferred Stock
2016-07-06−5,000,000→ 0 total
Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2016-07-06+1,333,333→ 1,813,332 total
Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2016-07-06+423,805→ 4,237,137 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2016-07-06$12.50/sh+400,000→ 4,637,137 total
Conversion
Syros Pharmaceuticals, Inc.
Series A-3 Preferred Stock
2016-07-06−7,500,000→ 0 total
Conversion
Syros Pharmaceuticals, Inc.
Series B Preferred Stock
2016-07-06−1,589,269→ 0 total
Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2016-07-06+266,666→ 479,999 total
Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2016-07-06+2,000,000→ 3,813,332 total
Other
Juno Therapeutics, Inc.
Common Stock
2016-03-15−1,000,000→ 10,552,390 total
Other
Sage Therapeutics, Inc.
Common Stock
2015-06-18−1,062,345→ 2,124,699 total
Other
AGIOS PHARMACEUTICALS, INC.$AGIO
Common Stock
2015-02-19−386,074→ 3,088,590 total
Other
Sage Therapeutics, Inc.
Common Stock
2015-01-14−1,062,345→ 3,187,044 total
Conversion
Juno Therapeutics, Inc.
Common Stock
2014-12-23+3,747,500→ 11,094,515 total
Conversion
Juno Therapeutics, Inc.
Series A Preferred Stock
2014-12-23−6,250,000→ 0 total
Conversion
Juno Therapeutics, Inc.
Series B Preferred Stock
2014-12-23−457,875→ 0 total
Conversion
Juno Therapeutics, Inc.
Common Stock
2014-12-23+6,250,000→ 7,347,015 total
Conversion
Juno Therapeutics, Inc.
Common Stock
2014-12-23+457,875→ 11,552,390 total
Conversion
Juno Therapeutics, Inc.
Series A-2 Preferred Stock
2014-12-23−3,747,500→ 0 total
Conversion
Sage Therapeutics, Inc.
Common Stock
2014-07-23+1,587,301→ 1,587,301 total
Conversion
Sage Therapeutics, Inc.
Common Stock
2014-07-23+2,380,951→ 3,968,252 total
Conversion
Sage Therapeutics, Inc.
Series A Preferred Stock
2014-07-23−5,000,000→ 0 total
Conversion
Sage Therapeutics, Inc.
Series C Preferred Stock
2014-07-23−885,583→ 0 total
Conversion
Sage Therapeutics, Inc.
Common Stock
2014-07-23+281,137→ 4,249,389 total
Conversion
Sage Therapeutics, Inc.
Series B Preferred Stock
2014-07-23−7,500,000→ 0 total
Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common Stock
2013-07-29+3,860,738→ 3,860,738 total
Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Series C-2 Convertible Preferred Stock
2013-07-29−617,031→ 0 total
Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Series A Convertible Preferred Stock
2013-07-29−10,000,000→ 0 total
Conversion
bluebird bio, Inc.
Series D Convertible Preferred Stock
2013-06-24−14,047,762→ 0 total
Conversion
bluebird bio, Inc.
Series C Convertible Preferred Stock
2013-06-24−19,971,242→ 0 total
Conversion
bluebird bio, Inc.
Common Stock
2013-06-24+1,793,588→ 1,793,588 total
Conversion
Receptos, Inc.
Common Stock
2013-05-14+129,755→ 129,755 total
Conversion
Receptos, Inc.
Common Stock
2013-05-14+1,022,283→ 1,136,568 total

Companies

Recent Filings

Address

8725 WEST HIGGINS ROAD, SUITE 290

CHICAGO, IL, 60631

View on SEC.gov